ARCA biopharma

$3.84
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-2.78%) As of 10:12 AM EDT today

Why Robinhood?

You can buy or sell ARCA biopharma and other stocks, options, and ETFs commission-free!

About ABIO

ARCA biopharma, Inc. Common Stock, also called ARCA biopharma, is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. Read More The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO. The listed name for ABIO is ARCA biopharma, Inc. Common Stock.

Employees
13
Headquarters
Westminster, Colorado
Founded
1992
Market Cap
22.38M
Price-Earnings Ratio
Dividend Yield
Average Volume
279.75K
High Today
$3.91
Low Today
$3.76
Open Price
$3.87
Volume
139.98K
52 Week High
$22.00
52 Week Low
$2.21

Collections

ABIO Earnings

-$1.98
-$1.32
-$0.66
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 4, After Hours

You May Also Like